Clinical Trials Sponsored by White, Katharine O'Connell, M.D., M.P.H.
Total 1 results
-
White, Katharine O'Connell, M.D., M.P.H.Society of Family PlanningCompleted
Sponsors and Collaborators
- Iyad Naeem Muhammad, PhD
- Rivierduinen, Centre for Personality disorders Jelgersma
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- University of Applied Sciences Jena
- Gunkang Pharmaceuticals, Inc
- Korea Otsuka International Asia Arab
- Arsha Vidya Tirtha
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Eurotrials Brasil Consultores Cientificos Ltda
- Oblikue Consulting
- Paulo Sérgio Gomes Nogueira Borges
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- S-Biotek Holding ApS
- Foshan Sanshui District People's Hospital
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- United States Department of Defense (DOD)
- Lilly PharmaceuticalCompany
- Plethora Solutions Ltd
- Julian Taylor Green
- Sudimplant SAS - Groupe TBR
- View Full List
Medical Conditions
- Malaria,Falciparum
- Hypothermia Following Anesthesia, Sequela
- Brain Tumor, Primary
- Serum Albumin Low
- Immunologically-induced Lung Disease
- Chemotherapy-Induced Neutropenia
- Puberty, Delayed
- Vibration; Exposure
- Anemia Acute
- Testicular Teratoma
- Advance Directive Completion
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Deformity Flexion
- Thyroid and Parathyroid Surgery
- Blepharospasm of Both Eyelids
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Huntington Chorea
- Visual Attention Span Deficit
- Gray Platelet Syndrome
- View Full List
Drug Interventions
- Acalabrutinib in combination with VR
- Vosaroxin
- Oxycodone
- Mineralocorticoid receptor antagonist
- Celecoxib
- Ebselen
- Cyanoacrylate
- Pegfilgrastim
- Bimatoprost 0.03% eye drops
- F520
- Pemetrexed
- ABY-035 i.v.
- Cytisine
- S-Adenosyl-Methionine
- Standard medical therapy
- Rovalpituzumab tesirine
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- MMV390048 120mg
- Sorafenib
- Furmonertinib 160 mg
- View Full List
CROs by country
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Congo
- Contract Research Organizations in Egypt
- Contract Research Organizations in Estonia
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Israel
- Contract Research Organizations in Italy
- Contract Research Organizations in Kenya
- Contract Research Organizations in Morocco
- Contract Research Organizations in Philippines
- Contract Research Organizations in Qatar
- Contract Research Organizations in Türkiye
- Contract Research Organizations in Venezuela
- CRO list by country